A record number of Argentine companies attended the largest international biotechnology trade show

“BIO International Convention 2022”, one of the most important global meetings in the sector, took place this week in the city of San Diego, USA.

The Argentine Ministry of Foreign Affairs, through the Argentine Investment and International Trade Promotion Agency, coordinated the presence of Argentine biotechnology companies at "BIO International Convention 2022"- one of the most prominent global meetings for the sector, which took place in the city of San Diego, USA, from June 13th to 16th.

The Argentine pavilion was made up of 21 companies from the provinces of Santa Fe and Buenos Aires and the City of Buenos Aires, with a space to obtain information about 60 Argentine startups. The presence of Argentine companies in this edition has been a record, according to the biotechnology companies. They also highlighted Argentina's leading role as representative of Latin America.

On May 20th, the Minister of Foreign Affairs, Santiago Cafiero, together with the Secretary of International Economic Relations, Cecilia Todesca Bocco, received representatives of the participating companies to share the Ministry of Foreign Affairs’ interest in promoting and positioning Argentina as a supplier of knowledge-based goods and services, science and technology abroad.

Cafiero emphasized that "the best way to represent the country is through the companies and entrepreneurs that show the work and talent incorporated into national production".

BIO is one of the leading global meetings in the sector and has provided strategic meetings and marketing opportunities for the industry since 1993. The expo takes place every year in different cities in the USA and brings together the main international companies as well as SMEs, start-ups, and universities. This year, the focus of the event will be on the pharmaceutical industry and there will be different promotion and training sessions related to different areas in biotechnology and nanotechnology.

Graciela Ciccia, head of Innovation and Technological Development of INSUD Group and member of the Argentine Chamber of Biotechnology, said: "We are very pleased with our participation at BIO, San Diego. After two years, we returned to the Argentine pavilion with 21 mature companies and startups with AAICI's support. We had several business meetings where we showcased our products and technological platforms that combine biotechnology, nanotechnology, microfluidics and bioinformatics within the knowledge-based economy. We also participated in conferences where the advances and challenges of the sector in a post-pandemic world were discussed. We have human resources of high scientific and technological level, productive capacity and creativity. Argentina has an enormous growth potential in this sector".

Rubén Salim, from the startup Untech, said: "It has been a great experience for us. There are various reasons for this. We have been able to get suppliers of items we needed. Sharing with other Argentine companies has also been very positive. This is our first time at BIO, and it has helped us open our minds to continue thinking big. Both Argentina and the fair have been excellently organized. Our expectations have been surpassed”.

Gabriela Gutiérrez, a CONICET researcher who accompanied the startups, remarked: "Being at BIO for the first time is like being at the Soccer World Cup. The feeling of pride when arriving and seeing Argentina's stand and the emotion of being part of it, together with the industry's big players who accompanied us. We met scientists, companies, startups and investors from all over the world. We felt that we added value to whatever we did”.

Argentine government policies to promote biotechnology in the country were implemented in 2007. These policies were set forth by the Law for the Promotion of the Development and Production of Modern Biotechnology and the 2020 Law on Knowledge Economy, which have laid the foundations for a highly competitive industry.

Considering the main products in which biotechnology is used to obtain goods and services, Argentina shipped products from the biotechnology sector for almost US$ 1.5 billion in 2021, an increase of +17.4% compared to 2020.

In addition, in the first four months of 2022, shipments of biotechnology products reached US$ 447.9 million, a 12% increase compared to the same period in 2020. It should be noted that this is also the highest value for the first four months of the year in the last six years.

In this edition of BIO, the Argentine official delegation was made up of the following companies: Gador, Bagó Biprofarma, Argenomix, Romikin, Laboratorio Elea Phoenix SA, Insud, Bioceres, Biogénesis Bagó, Mabxience, Untech SAS, Amega Biotech, Gemabiotech SAU, Sinergium Biotech SAU, Microgenesis SAU, Laboratorios Richmond SACIF, Stamm Vegh SAU, Latinaba SRL, Bioeutectics SA, Kheiron SA, Wiener Laboratorios SAIC and Carpe Scheider & Cía. SA.

Contact us

+54 11 5199 2263

Carlos Pellegrini 675 9º (C1009ABM)
Paraguay 864 (C1057AAL)
Buenos Aires, Argentina